default author photo

Daiki Higuchi

National Cancer Center Research Institute

SCHOLARLY PAPERS

2

DOWNLOADS

88

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Excellent Concordance of the Molecular Classification between Preoperative Biopsy and Final Hysterectomy in Endometrial Carcinoma

Number of pages: 58 Posted: 23 Jul 2024
National Cancer Center Hospital, National Cancer Center Research Institute, National Cancer Center Research Institute, National Cancer Center Research Institute, affiliation not provided to SSRN, National Cancer Center Research Institute, National Cancer Center Research Institute, National Cancer Center Research Institute, Showa University - Department of Obstetrics and Gynecology, National Cancer Center Hospital, National Cancer Center Research Institute, National Cancer Center Hospital, National Cancer Center Research Institute and National Cancer Center Hospital
Downloads 58 (980,173)

Abstract:

Loading...

endometrial cancer, molecular classification, endometrial biopsy, concordance rate

2.

Alterations in the Tp53 Gene and Associated Pathway Drive Development Og a Gastric-Type Adenocarcinoma Rather than the Usual-Type Endocervical Adenocarcinoma

Number of pages: 34 Posted: 27 Jun 2024
National Cancer Center Research Institute, National Cancer Center Research Institute, National Cancer Center Research Institute, National Cancer Center Hospital, National Cancer Center Research Institute, Showa University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Research Institute, National Cancer Center Research Institute, Juntendo University - Juntendo University Hospital, Showa University, Showa University, National Cancer Center Hospital, National Cancer Center Research Institute, National Cancer Center Hospital, affiliation not provided to SSRN, National Cancer Center Research Institute and National Cancer Center Hospital
Downloads 30 (1,318,317)

Abstract:

Loading...

cervical cancer, Next-Generation Sequencing, Transcriptome, Metabolome analysis, HPV-independent, TP53 mutation